Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nano MRI on 7 Tesla in rectal and breast cancer
2014-005011-17Phase 3Active
- Sponsor
- Radboudumc
- Start
- Jan 2015
- Modality
- Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ferumoxtran-10 in rectal cancer, breast cancer and cancer, sponsored by Radboudumc. Primary endpoint: Sensitivity and specificity of 7T MRI with Sinerem. Started Jan 2015; status: active.
02
Drugs
ferumoxtran-10
03
Conditions
rectal cancerbreast cancercancer
Beyond the preview
Go deeper on 2014-005011-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005011-17.